Tough on the tumor

Easier on you and your caregivers

Get a head STaRT in the fight against brain tumors

A radiation treatment specifically designed for use inside the brain, GammaTile Therapy gives patients new hope in the fight against brain tumors. It can eliminate the need for traditional repeat radiation treatments and associated hospital or clinic visits, so patients can focus on what matters most—healing.

The neurosurgeon places GammaTile(s) precisely where and when treatment will help the most—immediately after tumor removal.

Radiation is focused right where it is needed and away from healthy brain tissue.[1]

GammaTile is designed to protect healthy brain tissue, limiting side effects from radiation.[3]

There is no need for an extra hospital stay, additional copays, or travel for ongoing radiation treatments.

Get a head STaRT in the fight against brain tumors. 

Find a GammaTile Therapy Center near you.

GammaTile Therapy: Clinical Outcomes

For patients with recurrent meningiomas and/or recurrent brain metastases, the use of GammaTile Therapy demonstrated a significant delay in treatment site recurrence compared to their previous treatments.

Doubled time recurrence-free in treatment area in recurrent meningiomas and recurrent brain metastases

PATIENTS WITH MENINGIOMAS AT 2 YEARS[4]

PATIENTS WITH BRAIN METASTASES AT 1 YEAR[5]

Potential to extend overall survival

in recurrent high grade gliomas

GammaTile Therapy demonstrates a potential for improved overall survival when comparing the effectiveness of GammaTile Therapy to other treatment modalities across different clinical studies in patients with recurrent high-grade gliomas.

PATIENTS WITH HIGH-GRADE GLIOMAS AT 1 YEAR

Learn about the company that developed GammaTile Therapy.

  1. Brachman D, Youssef E, Dardis C et al. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas. J Neurosurg. 2019;131(6):1819-1828. doi:10.3171/2018.7.jns18656

  2. Stupp R, Wong ET, Kanner AA, et al. NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment  modality.
    Euro J Cancer. 2012; 48(14):2192-2202.

  3. Brachman D, Youssef E, Dardis C, Smith K, Pinnaduwage D, Nakaji P. Surgically targeted radiation therapy: Safety profile of collagen tile brachytherapy in 79 recurrent, previously irradiated intracranial neoplasms on a prospective clinical trial. Brachytherapy. 2019;18(3):S35-S3

  4. Brachman, D, Rogers, C, et al. Resection and surgically targeted radiation therapy for initial or salvage treatment of aggressive meningioma: results from a prospective trial. Poster presented at: CNS 2020 Virtual Conference; September 30, 2020.

  5. Brachman, D, Nakaji, P, et al. A prospective trial of resection plus surgically targeted radiation therapy for brain metastasis. Poster presented at: SNO 2020 Virtual Conference on Brain Metastases; August 14, 2020. 

  6. Data on file, GT Medical Technologies, Inc.

TREATMENT CONSIDERATIONS 

GammaTile Therapy is intended to deliver radiation therapy in patients with newly diagnosed malignant brain tumors and recurrent brain tumors. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

CONNECT WITH US
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube

©2020 GT Medical Technologies, Inc. I All rights reserved | Privacy Policy | Terms of Use

IMPROVING THE LIVES OF PATIENTS WITH BRAIN TUMORS